Seeing Is Believing
Currently out of the existing stock ratings of Graham Doyle, 9 are a SELL (27.27%), 14 are a HOLD (42.42%), 10 are a BUY (30.3%).
Analyst Graham Doyle, currently employed at UBS, carries an average stock price target met ratio of 50% that have a potential upside of 25.04% achieved within 236 days.
Graham Doyle’s has documented 52 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on FMS, Fresenius Medical Care at 01-Sep-2025.
Analyst best performing recommendations are on PHG (KONINKLIJKE PHILIPS NV ADR).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 9/2/2022. The price target of $16.49 was fulfilled within 7 days with a profit of $1.5 (10.01%) receiving and performance score of 14.3.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
7 months 19 days ago
(11-Mar-2025)
0/3 (0%)
$-10.44 (-43.85%)
Hold
$27
$-9.59 (-26.21%)
$32
8 months 5 days ago
(25-Feb-2025)
3/5 (60%)
$-1.22 (-4.32%)
656
Buy
$15.29
$-21.3 (-58.21%)
$15.07
1 years 11 months 28 days ago
(02-Nov-2023)
7/14 (50%)
$-7.54 (-33.03%)
673
Buy
$33
$-3.59 (-9.81%)
$39.5
2 years 27 days ago
(03-Oct-2023)
1/2 (50%)
$10.75 (48.31%)
671
Buy
$16.94
$-19.65 (-53.70%)
$14.12
2 years 6 months 20 days ago
(10-Apr-2023)
0/3 (0%)
$-10.46 (-38.18%)
Which stock is Graham Doyle is most bullish on?
What Year was the first public recommendation made by Graham Doyle?